Use and Outcomes of Low-Dose CT Scan Lung Cancer Screening in the Medicare Population.

ABSTRACT:

Background

Relatively little is known about various aspects of low-dose CT (LDCT) scan lung cancer screening in US clinical practice, including characteristics of cases diagnosed after screening. We assessed this using the Surveillance, Epidemiology, and End Results (SEER)-Medicare database.

Research question

What were the characteristics of patients with lung cancer, including stage and survival, whose disease was diagnosed after LDCT scan screenings?

Study design and methods

We created an LDCT scan use cohort consisting of everyone in the 5% SEER-Medicare sample with ≥ 12 months of non-health maintenance organization (HMO) Part A and B coverage while 65 to 77 years of age from 2015 through 2019. LDCT scan use and lung cancer diagnosis rates were assessed in this coh

SUBMITTER: Pinsky PF 

PROVIDER: S-EPMC9470736 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature